Dr. Anuja Jhingran, MD
Claim this profileStudies Cervical Cancer
1 reported clinical trial
4 drugs studied
Area of expertise
1Cervical Cancer
Stage II
Stage I
More about Anuja Jhingran, MD
Clinical Trial Related16 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Anuja Jhingran, MD has experience with
- Carboplatin
- Cisplatin
- Paclitaxel
- Pelvic Radiation Therapy
Breakdown of trials Anuja Jhingran, MD has run
Cervical Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Anuja Jhingran, MD specialize in?
Anuja Jhingran, MD focuses on Cervical Cancer and other conditions. In particular, much of their work with Cervical Cancer has involved Stage II patients, or patients who are Stage I.
Is Anuja Jhingran, MD currently recruiting for clinical trials?
No, Anuja Jhingran, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Anuja Jhingran, MD has studied deeply?
Yes, Anuja Jhingran, MD has studied treatments such as Carboplatin, Cisplatin, Paclitaxel.
What is the best way to schedule an appointment with Anuja Jhingran, MD?
Apply for one of the trials that Anuja Jhingran, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.